Image Source: TypoArt BS,Shutterstock
- REACT Group plc has been awarded a new contract to supply a full range of reactive or deep cleaning and decontamination services.
- Induction Healthcare Group Plc has signed contracts with three well-known hospitals of South East England.
Returning confidence among the business and the people have started appearing soon after the nation went for a major phase of reopening. Businesses are ramping up their work and production, and people are also adapting to the new normal. Though there is still some sense of fear with social distancing in place, but the regular contract process by the businesses is showing that how the nation is moving back to the growth path. A quick look at the deals:
REACT Group Plc (LON: REAT)
The AIM-listed company offers different services of hygiene, cleaning and decontamination. On Monday, it announced that it has been awarded a new contract to supply a full range of reactive or deep cleaning and decontamination services to one of the world's leading facility management companies for up to three years.
As per the contract, REACT has been specified as the core vendor by one of its existing customers and will provide cover to a portfolio of over 2,000 different locations through mainland Great Britain. This contract is a part of a business strategy to remove different supply chains in one category of work, from several hundred smaller suppliers to just one.
The portfolio and figure have expanded due to Covid-19, REACT has commenced offering services under the contract immediately.
The stock of the company was trading at GBX 3.00, up by 17.65 per cent at 15:30 PM GMT +1 from its previous closing. In the last one year, the stock has given the return of over 156 per cent.
Induction Healthcare Group Plc (LON: INHC)
It is a UK-based virtual care platform that offers different facilities such as share document, directory services to healthcare professionals and patients.
The company has announced that it has signed contracts with three well-known hospitals in South East England to implement Induction Zesty to provide them with their digital patient portals. The contract is for a period of 12 to 20 months and is worth a total of £440,000.
These contracts will result in a change in the healthcare sector by providing the different facilities that allow patients to take control of their clinical records, correspondence, and appointments from the convenience of their system and smartphone. Joint CEO James Balmain has said that the new contracts have bolstered the company’s position of annual recurring revenue and momentum of sales.
The stock of the Induction was trading at GBX 104.00, up by 1.46 per cent at 15:38 PM GMT +1 from its previous closing. In the last one year the stock has given the return of around 13 per cent.
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal